Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Marketaxess Holdings (MKTX) Research & Development (2016 - 2025)

Historic Research & Development for Marketaxess Holdings (MKTX) over the last 16 years, with Q3 2025 value amounting to $20.0 million.

  • Marketaxess Holdings' Research & Development rose 758.91% to $20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year increase of 795.72%. This contributed to the annual value of $72.2 million for FY2024, which is 1491.22% up from last year.
  • According to the latest figures from Q3 2025, Marketaxess Holdings' Research & Development is $20.0 million, which was up 758.91% from $19.4 million recorded in Q2 2025.
  • Over the past 5 years, Marketaxess Holdings' Research & Development peaked at $20.0 million during Q3 2025, and registered a low of $10.0 million during Q1 2021.
  • For the 5-year period, Marketaxess Holdings' Research & Development averaged around $15.1 million, with its median value being $15.2 million (2023).
  • In the last 5 years, Marketaxess Holdings' Research & Development soared by 3285.51% in 2022 and then skyrocketed by 584.72% in 2025.
  • Over the past 5 years, Marketaxess Holdings' Research & Development (Quarter) stood at $11.2 million in 2021, then grew by 25.68% to $14.1 million in 2022, then rose by 22.07% to $17.2 million in 2023, then grew by 9.07% to $18.8 million in 2024, then increased by 6.23% to $20.0 million in 2025.
  • Its Research & Development was $20.0 million in Q3 2025, compared to $19.4 million in Q2 2025 and $18.0 million in Q1 2025.